Skip to content

An Observational Study of the NeuroBell EEG Monitor

An Observational Study of the NeuroBell EEG Monitor (a Portable and Wireless EEG Monitor)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07508670
Enrollment
17
Registered
2026-04-02
Start date
2024-09-02
Completion date
2026-03-03
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EEG, Hypoxic Ischaemic Encephalopathy (HIE), Medical Devices, Neonatal Seizures, Neonatology, Neurology, Seizure

Keywords

Observational, Neonatal seizure, medical device

Brief summary

An observational clinical investigation of the NeuroBell EEG Monitor (a portable and wireless EEG monitor).

Detailed description

The objective of the clinical investigation is to evaluate the signal quality of the NeuroBell EEG Monitor (hereinafter referred to as the investigational device) for use in acquiring neonatal EEG compared to a conventional EEG device.

Interventions

DEVICENeuroBell EEG Monitor

EEG Monitor

Sponsors

University College Cork
Lead SponsorOTHER
NeuroBell Ltd
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months
Healthy volunteers
No

Inclusion criteria

* Full-term neonates (born between 36-44 weeks gestational age), in whom EEG monitoring is indicated as part of standard clinical care or as part of a separate study in which they are enrolled

Exclusion criteria

* Do not meet inclusion criteria * No parental/guardian consent.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of EEG signals from investigational device compared with standard of care EEG deviceFrom enrollment to the end off EEG analysisEEG signals recorded by the investigational device will be compared to the EEG signals recorded by the conventional EEG monitor. Confirmation that the investigational device records EEG signals are suitable for clinical interpretation.

Countries

Ireland

Contacts

PRINCIPAL_INVESTIGATORBrian Walsh, MD

Cork University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026